Piperdine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication

    公开(公告)号:US07355051B2

    公开(公告)日:2008-04-08

    申请号:US10596519

    申请日:2004-12-20

    IPC分类号: C07D401/106

    CPC分类号: C07D401/14 C07D417/14

    摘要: The present invention concerns piperidine-amino-benzimidazoles having inhibitory activity on the replication of the respiratory syncytial virus and having the formula their prodrugs, N-oxides, addition salts, quaternary amines, metal complexes and stereochemically isomeric forms wherein Q is C1−6alkyl optionally substituted with trifluoromethyl, C3-7cycloalkyl, Ar2, hydroxy, C1−4alkoxy, C1−4alkylthio, Ar2-oxy-, Ar2-thio-, Ar2(CH2)noxy, Ar2(CH2)nthio, hydroxycarbonyl, aminocarbonyl, C1−4alkyl-carbonyl, Ar2carbonyl, C1−4alkoxycarbonyl, Ar2(CH2)ncarbonyl, aminocarbonyloxy, C1−4alkylcarbonyloxy, Ar2carbonyloxy, Ar2(CH2)ncarbonyloxy, C1−4alkoxy-carbonyl(CH2)noxy, mono- or di(C1−4alkyl)aminocarbonyl, mono- or di(C1−4alkyl)-aminocarbonyloxy, aminosulfonyl, mono- or di(C1−4alkyl)aminosulfonyl or a heterocycles selected from the group consisting of pyrrolidinyl, pyrrolyl, dihydropyrrolyl, imidazolyl, triazolyl, piperidinyl, homopiperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, 1-oxo-thiomorpholinyl, 1,1-dioxothiomorpholinyl, pyridyl and tetrahydropyridyl, wherein each of said heterocycle may optionally be substituted with oxo or C1−6alkyl; G is a direct bond or optionally substituted C1-10alkanediyl; R1 is Ar1 or a monocyclic or bicyclic heterocycle; one of R2a and R3a is C1−6alkyl and the other one of R2a and R3a is hydrogen; in case R2a is different from hydrogen then R2b is hydrogen or C1−6alkyl, and R3b is hydrogen; in case R3a is different from hydrogen then R3b is hydrogen or C1−6alkyl, and R2b is hydrogen; t is 1, 2 or 3; Ar1 is phenyl or substituted phenyl; and Ar2 is phenyl or substituted phenyl. It further concerns their preparation and compositions comprising them, as well as their use as a medicine.

    AMINO-BENZIMIDAZOLES DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION
    2.
    发明申请
    AMINO-BENZIMIDAZOLES DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION 审中-公开
    氨基苯并咪唑衍生物作为呼吸道同发病毒复制的抑制剂

    公开(公告)号:US20090036466A1

    公开(公告)日:2009-02-05

    申请号:US10596500

    申请日:2004-12-20

    摘要: The present invention concerns amino-benzimidazoles having inhibitory activity on the replication of the respiratory syncytial virus and having the formula their prodrugs, N-oxides, addition salts, quaternary amines, metal complexes and stereochemically isomeric forms wherein Q is Ar1 or C1-6alkyl substituted with one or more substituents selected from trifluoromethyl, C3-7cycloalkyl, Ar2, hydroxy, C1-4alkoxy, C1-4alkylthio, Ar2-oxy-, Ar2-thio-, Ar2(CH2)noxy, Ar2(CH2)nthio, hydroxycarbonyl, aminocarbonyl, C1-4alkylcarbonyl, Ar2-carbonyl, C1-4alkoxycarbonyl, Ar2(CH2)ncarbonyl, aminocarbonyloxy, C1-4alkylcarbonyloxy, Ar2-carbonyloxy, Ar2(CH2)ncarbonyloxy, hydroxy-C2-4-alkyloxy, C1-4alkoxycarbonyl(CH2)noxy, mono- or di(C1-4alkyl)-aminocarbonyl, mono- or di(C1-4alkyl)aminocarbonyloxy, aminosulfonyl, mono- or di(C1-4alkyl)aminosulfonyl, dioxolanyl optionally substituted with one or two C1-6alkyl radicals, and a heterocycle selected from pyrrolidinyl, pyrrolyl, dihydropyrrolyl, thiazolidinyl, imidazolyl, triazolyl, piperidinyl, homopiperidinyl, piperazinyl, pyridyl and tetrahydropyridyl, which each may optionally be substituted with oxo or C1-6alkyl; G is a direct bond or optionally substituted C1-10alkanediyl R1 is Ar1 or a monocyclic or bicyclic heterocycle; one of R2a and R3a is C1-6alkyl and the other one of R2a and R3a is hydrogen; in case R2a is different from hydrogen then R2b is hydrogen or C1-6alkyl, and R3b is hydrogen; in case R3a is different from hydrogen then R3b is hydrogen or C1-6alkyl, and R2b is hydrogen; Ar1 is phenyl or substituted phenyl and Ar2 is phenyl or substituted phenyl. It further concerns their preparation and compositions comprising them, as well as their use as a medicine.

    摘要翻译: 本发明涉及对呼吸道合胞病毒复制具有抑制活性的氨基苯并咪唑,其具有其前药,N-氧化物,加成盐,季胺,金属络合物和立体化学异构体形式,其中Q为Ar 1或C 1-6烷基取代 具有一个或多个选自三氟甲基,C 3-7环烷基,Ar 2,羟基,C 1-4烷氧基,C 1-4烷硫基,Ar 2 - 氧基 - ,Ar 2 - 硫基 - ,Ar 2(CH 2)n羟基,Ar 2(CH 2)n硫基,羟基羰基,氨基羰基 ,C 1-4烷基羰基,Ar 2 - 羰基,C 1-4烷氧基羰基,Ar 2(CH 2)n羰基,氨基羰基氧基,C 1-4烷基羰基氧基,Ar 2 - 羰基氧基,Ar 2(CH 2)n - 羰基氧基,羟基-C 2-4 4-烷氧基,C 1-4烷氧基羰基(CH 2) 一或二(C 1-4烷基) - 氨基羰基,一或二(C 1-4烷基)氨基羰基氧基,氨基磺酰基,一或二(C 1-4烷基)氨基磺酰基,任选被一个或两个C 1-6烷基取代的二氧戊环基, 选自吡咯烷基,吡咯基,二氢吡咯基,噻唑烷基的杂环 ,咪唑基,三唑基,哌啶基,高哌啶基,哌嗪基,吡啶基和四氢吡啶基,其各自可以任选被氧代或C 1-6烷基取代; G是直接键或任选取代的C 1-10烷二基R 1是Ar 1或单环或双环杂环; R2a和R3a之一是C1-6烷基,R2a和R3a中的另一个是氢; 在R2a不同于氢的情况下,则R2b为氢或C1-6烷基,R3b为氢; 在R3a不同于氢的情况下,R 3b是氢或C 1-6烷基,R 2b是氢; Ar 1是苯基或取代的苯基,Ar 2是苯基或取代的苯基。 它还涉及它们的制备方法和包含它们的组合物,以及它们作为药物的用途。

    5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
    5.
    发明授权
    5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication 有权
    5-或6-取代的苯并咪唑衍生物作为呼吸道合胞病毒复制的抑制剂

    公开(公告)号:US08278455B2

    公开(公告)日:2012-10-02

    申请号:US12253450

    申请日:2008-10-17

    IPC分类号: A61K31/4439 C07D401/06

    摘要: The present invention concerns 5- or 6-substituted-benzimidazole derivatives having inhibitory activity on the replication of the respiratory syncytial virus and having the formula a prodrug, N-oxide, addition salt, quaternary amine, metal complex or stereochemically isomeric form thereof wherein Q is Ar2, R6, pyrrolidinyl substituted with R6, piperidinyl substituted with R6 or homopiperidinyl substituted with R6, G is a direct bond or optionally substituted C1-10alkanediyl; R1 is Ar1 or a monocyclic or bicyclic heterocycle; one of R2a and R2b is cyanoC1-6alkyl, cyanoC2-6alkenyl, Ar3C1-6alkyl, Het1C1-6alkyl, N(R8aR8b)C1-6alkyl, Ar3C2-6alkenyl, Het1C2-6alkenyl, Ar3aminoC1-6alkyl, Het1aminoC1-6alkyl, Ar3thioC1-6alkyl, Het1thioC1-6alkyl, Ar3sulfonylC1-6alkyl, Het1sulfonylC1-6alkyl, Ar3aminocarbonyl, Het1aminocarbonyl, Ar3(CH2)namino-carbonyl, Het1(CH2)naminocarbonyl, Ar3carbonylamino, Het1carbonylamino, Ar3(CH2)ncarbonylamino, Het1(CH2)ncarbonylamino, and the other one of R2a and R2b is hydrogen; in case R2a is hydrogen, then R3 is hydrogen; in case R2b is hydrogen, the R3 is hydrogen or C1-6alkyl. It further concerns their preparation and compositions comprising them, as well as their use as a medicine.

    摘要翻译: 本发明涉及对呼吸道合胞病毒复制具有抑制活性的5-或6-取代苯并咪唑衍生物,其具有前药,N-氧化物,加成盐,季胺,金属络合物或其立体化学异构形式,其中Q 是Ar 2,R 6,被R 6取代的吡咯烷基,被R 6取代的哌啶基或被R 6取代的高哌啶基,G是直接键或任意取代的C 1-10烷二基; R1是Ar1或单环或双环杂环; R2a和R2b之一是氰基C 1-6烷基,氰基C 2-6烯基,Ar 3 C 1-6烷基,Het 1 C 1-6烷基,N(R 8 a R 8 b)C 1-6烷基,Ar 3 C 2-6烯基,Het 1 C 2-6烯基,Ar 3氨基C 1-6烷基,Het 1氨基C 1-6烷基,Ar 3硫代C 1-6烷基, (CH 2)n氨基 - 羰基,Het 1(CH 2)n氨基羰基,Ar 3羰基氨基,Het 1羰基氨基,Ar 3(CH 2)n - 羰基氨基,Het 1(CH 2)n - 羰基氨基,和另一个(CH 2)n C 1 -C 6烷基, R2a和R2b是氢; 在R2a为氢的情况下,R3为氢; 在R2b为氢的情况下,R3为氢或C1-6烷基。 它还涉及它们的制备方法和包含它们的组合物,以及它们作为药物的用途。

    ANTIBACTERIAL QUINOLINE DERIVATIVES
    10.
    发明申请
    ANTIBACTERIAL QUINOLINE DERIVATIVES 审中-公开
    抗生素喹啉衍生物

    公开(公告)号:US20110166179A1

    公开(公告)日:2011-07-07

    申请号:US12516396

    申请日:2007-12-04

    摘要: The present invention relates to novel substituted quinoline derivatives according to the general formula (Ia) or formula (Ib): including any stereochemically isomeric form thereof, a N-oxide thereof, a pharmaceutically acceptable salt thereof or a solvateas thereof. The claimed compounds are useful for the treatment of a bacterial infection. Also claimed is a composition comprising a pharmaceutically acceptable carrier and, as active ingredient, a therapeutically effective amount of the claimed compounds, the use of the claimed compounds or compositions for the manufacture of a medicament for the treatment of a bacterial infection and a process for preparing the claimed compounds.

    摘要翻译: 本发明涉及根据通式(Ia)或式(Ib)的新的取代喹啉衍生物:包括其任何立体化学异构形式,其N-氧化物,其药学上可接受的盐或溶剂化物。 所要求保护的化合物可用于治疗细菌感染。 还要求保护的是包含药学上可接受的载体和作为活性成分的治疗有效量的要求保护的化合物的组合物,所要求保护的化合物或组合物在制备用于治疗细菌感染的药物中的用途和 制备所要求的化合物。